A detailed history of Nuveen Asset Management, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 151,726 shares of PRTA stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
151,726
Previous 152,353 0.41%
Holding current value
$1.91 Million
Previous $3.14 Million 19.27%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.73 - $24.79 $10,489 - $15,543
-627 Reduced 0.41%
151,726 $2.54 Million
Q2 2024

Aug 09, 2024

SELL
$19.54 - $26.15 $1.77 Million - $2.37 Million
-90,669 Reduced 37.31%
152,353 $3.14 Million
Q1 2024

May 13, 2024

SELL
$24.75 - $40.66 $1.43 Million - $2.35 Million
-57,797 Reduced 19.21%
243,022 $6.02 Million
Q4 2023

Feb 14, 2024

SELL
$32.31 - $52.32 $4.41 Million - $7.14 Million
-136,451 Reduced 31.21%
300,819 $10.9 Million
Q3 2023

Nov 14, 2023

SELL
$47.3 - $70.6 $271,785 - $405,667
-5,746 Reduced 1.3%
437,270 $21.1 Million
Q2 2023

Aug 16, 2023

SELL
$48.26 - $78.59 $472,948 - $770,182
-9,800 Reduced 2.16%
443,016 $30.2 Million
Q2 2023

Aug 14, 2023

SELL
$48.26 - $78.59 $2.6 Million - $4.24 Million
-53,912 Reduced 10.64%
452,816 $30.9 Million
Q1 2023

May 15, 2023

SELL
$46.97 - $58.27 $3.1 Million - $3.85 Million
-66,062 Reduced 11.53%
506,728 $24.6 Million
Q4 2022

Feb 14, 2023

BUY
$52.05 - $65.0 $4.29 Million - $5.35 Million
82,338 Added 16.79%
572,790 $34.5 Million
Q3 2022

Nov 14, 2022

SELL
$25.16 - $60.63 $5.86 Million - $14.1 Million
-232,720 Reduced 32.18%
490,452 $29.7 Million
Q2 2022

Aug 15, 2022

SELL
$22.73 - $39.98 $18,570 - $32,663
-817 Reduced 0.11%
723,172 $19.6 Million
Q1 2022

May 16, 2022

BUY
$30.27 - $49.22 $6.84 Million - $11.1 Million
225,825 Added 45.33%
723,989 $27.3 Million
Q4 2021

Feb 14, 2022

BUY
$42.11 - $73.26 $790,362 - $1.38 Million
18,769 Added 3.92%
498,164 $24.6 Million
Q3 2021

Nov 12, 2021

BUY
$48.2 - $78.89 $1.42 Million - $2.32 Million
29,404 Added 6.53%
479,395 $34.1 Million
Q2 2021

Aug 16, 2021

BUY
$21.63 - $57.65 $1.67 Million - $4.45 Million
77,164 Added 20.7%
449,991 $23.1 Million
Q1 2021

May 17, 2021

SELL
$11.0 - $28.24 $15,653 - $40,185
-1,423 Reduced 0.38%
372,827 $9.37 Million
Q4 2020

May 17, 2021

SELL
$10.12 - $13.94 $159,592 - $219,833
-15,770 Reduced 4.04%
374,250 $4.5 Million
Q4 2020

Feb 16, 2021

BUY
$10.12 - $13.94 $82,710 - $113,931
8,173 Added 2.14%
390,020 $4.68 Million
Q3 2020

Nov 16, 2020

BUY
$9.93 - $13.47 $209,284 - $283,893
21,076 Added 5.84%
381,847 $3.82 Million
Q2 2020

Aug 14, 2020

SELL
$9.56 - $12.51 $1.45 Million - $1.9 Million
-151,535 Reduced 29.58%
360,771 $3.77 Million
Q1 2020

May 14, 2020

BUY
$7.54 - $15.77 $991,381 - $2.07 Million
131,483 Added 34.53%
512,306 $5.48 Million
Q4 2019

Feb 14, 2020

BUY
$7.48 - $17.01 $839,270 - $1.91 Million
112,202 Added 41.77%
380,823 $6.03 Million
Q3 2019

Nov 14, 2019

BUY
$6.89 - $10.45 $107,835 - $163,552
15,651 Added 6.19%
268,621 $2.11 Million
Q2 2019

Aug 15, 2019

BUY
$8.85 - $12.49 $2.24 Million - $3.16 Million
252,970 New
252,970 $2.67 Million
Q4 2017

Feb 14, 2018

SELL
$35.44 - $63.76 $667,158 - $1.2 Million
-18,825 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$53.83 - $67.75 $1.01 Million - $1.28 Million
18,825
18,825 $1.22 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $592M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.